NCT03626337

Brief Summary

A hospital- and community-based study in Luang Prabang, Lao PDR, which will include a group of hospitalized children 21 days to \<18 months of age who are diagnosed with symptoms compatible with thiamine deficiency disorder (TDD). Based on the infants' response to thiamine administration, children will be defined as either thiamine responsive disorder (TRD) cases or non-responders. A community-based comparison group of infants in the same age range will be included in the study to serve as a control group for identification of potential risk factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,394

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 13, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

June 17, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2021

Completed
Last Updated

August 15, 2022

Status Verified

August 1, 2022

Enrollment Period

1.7 years

First QC Date

July 17, 2018

Last Update Submit

August 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Thiamine Responsive Disorder (TRD)

    Diagnosis of TRD will be determined based on improvements of initially abnormal physical findings such as hepatomegaly, heart rate, and respiratory rate, and resolution of echocardiographic findings of enlarged and poorly functioning ventricles

    48-72 hours

Secondary Outcomes (2)

  • Biomarkers of whole blood thiamine diphosphate (ThDP) and erythrocyte transketolase activity coefficient (ETKac)

    Baseline

  • Hemoglobin and biomarkers of other micronutrients (ferritin, transferrin receptor, retinol binding protein, erythrocyte glutathione reductase activation coefficient (EGRAC)), and inflammation (CRP, AGP)

    Baseline

Study Arms (2)

Hospital-based cohort

100 mg thiamine provided via intramuscular and/or intravenous injection (Thiamine 100 MG/ML) daily for 3 days

Drug: Thiamine 100 MG/ML

Community-based cohort

Sex-, age- and regionally matched comparison group

Interventions

100 mg thiamine provided as intramuscular injection

Also known as: Standard of care
Hospital-based cohort

Eligibility Criteria

Age21 Days - 17 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized children: Infants and children in the target age range (21 days to \<18 months), who are admitted to the participating hospitals, will be screened by hospital staff to determine the presence of at least one of the inclusion criteria Community-based cohort: A sex-, age- and regionally-similar comparison group will be enrolled based on the characteristics of the hospitalized group. Mothers of all participating infants will be invited to the study.

You may qualify if:

  • Liver enlargement (\>2 cm below right costal margin on calm, supine exam)
  • Edema
  • Tachypnea (\> 60/min for 3-8 wks; \>50/min for 2-11 mo; \>40/min for 12 - 18 mo)
  • Tachycardia (heart rate \>160/min for \<12 mo; \>120/min for 12 mo - 18 mo)
  • Oxygen saturation (\<92%)
  • Difficulty breathing (i.e. chest in-drawing, nasal flaring)
  • Refusal to breastfeed or refusal of infant formula or food for greater than 24 hours
  • Repetitive or recurring vomiting with no obvious other cause(i.e. vomiting \>3 times in past 24 hours)
  • Persistent crying not relieved by soothing and feeding with no obvious other cause
  • Hoarse voice/cry or loss of voice
  • Nystagmus or other unusual eye movement
  • Muscle twitching
  • Loss of consciousness
  • Convulsion
  • Opisthotonus / abnormal posturing
  • +1 more criteria

You may not qualify if:

  • \- None
  • Children aged 21 days to \<18 months
  • Residing in selected communities
  • \- Severe acute illness warranting immediate hospital referral
  • \- Mother of hospital-based study participant or community-based study participant
  • Severe acute illness warranting immediate hospital referral
  • Unable to provide informed consent due to reduced decision making ability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lao Friends Hospital for Children

Luang Prabang, Laos

Location

Related Publications (5)

  • Hess SY, Smith TJ, Fischer PR, Trehan I, Hiffler L, Arnold CD, Sitthideth D, Tancredi DJ, Schick MA, Yeh J, Stein-Wexler R, McBeth CN, Tan X, Nhiacha K, Kounnavong S. Establishing a case definition of thiamine responsive disorders among infants and young children in Lao PDR: protocol for a prospective cohort study. BMJ Open. 2020 Feb 13;10(2):e036539. doi: 10.1136/bmjopen-2019-036539.

    PMID: 32060165BACKGROUND
  • Smith TJ, Tan X, Arnold CD, Sitthideth D, Kounnavong S, Hess SY. Traditional prenatal and postpartum food restrictions among women in northern Lao PDR. Matern Child Nutr. 2022 Jan;18(1):e13273. doi: 10.1111/mcn.13273. Epub 2021 Sep 30.

    PMID: 34595830BACKGROUND
  • Hess SY, Arnold CD, Smith TJ, Allen LH, Hampel D, Jones KS, Parkington DA, Meadows SR, Sitthideth D, Kounnavong S. Thiamine Concentration in Human Milk Is Correlated With Maternal and Infant Thiamine Status: A Cross-Sectional Analysis of the Lao Thiamine Study. Matern Child Nutr. 2025 Jul;21(3):e70027. doi: 10.1111/mcn.70027. Epub 2025 Apr 10.

  • Hess SY, Smith TJ, Arnold CD, Jones KS, Hampel D, Hiffler L, Trehan I, Fischer PR, Meadows SR, Parkington DA, Brown KH, Sitthideth D, Tan X, Koulman A, Allen LH, Kounnavong S. Assessment of Erythrocyte Transketolase, Whole Blood Thiamine Diphosphate, and Human Milk Thiamine Concentrations to Identify Infants and Young Children Responding Favorably to Therapeutic Thiamine Administration: Findings from the Lao Thiamine Study, a Prospective Cohort Study. Curr Dev Nutr. 2024 May 23;8(6):103786. doi: 10.1016/j.cdnut.2024.103786. eCollection 2024 Jun.

  • Smith TJ, Arnold CD, Fischer PR, Trehan I, Hiffler L, Sitthideth D, Stein-Wexler R, Yeh J, Jones KS, Hampel D, Tancredi DJ, Schick MA, McBeth CN, Tan X, Allen LH, Sayasone S, Kounnavong S, Hess SY. A Predictive Model for Thiamine Responsive Disorders Among Infants and Young Children: Results from a Prospective Cohort Study in Lao People's Democratic Republic. J Pediatr. 2024 May;268:113961. doi: 10.1016/j.jpeds.2024.113961. Epub 2024 Feb 17.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood, plasma and erythrocyte samples will be collected among children. Blood, plasma, erythrocyte and breastmilk samples will be collected among their mothers.

MeSH Terms

Conditions

Thiamine Deficiency

Interventions

ThiamineStandard of Care

Condition Hierarchy (Ancestors)

Vitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

ThiazolesSulfur CompoundsOrganic ChemicalsAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPyrimidinesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Sengchanh Kounnavong, MD, PhD

    Lao Tropical and Public Health Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2018

First Posted

August 13, 2018

Study Start

June 17, 2019

Primary Completion

February 25, 2021

Study Completion

February 25, 2021

Last Updated

August 15, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

The complete de-identified dataset will be made publically available. Associated data dictionaries will be made available along with the datasets.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Within 3 years after completion of data collection

Available IPD Datasets

Statistical Analysis Plan Access

Locations